Annals of Microbiology

, 56:47 | Cite as

Influence of medium design on lovastatin and mevastatin production byAspergillus terreus strains

  • Manuela Rollini
  • Matilde Manzoni
Industrial Microbiology Original Articles


In order to investigate the influence of medium design on lovastatin and mevastatin production byAspergillus terreus strains, several nitrogen complex sources, such as vegetal flour and peptones of different origin (animal and vegetal) were tested, together with the addition of methionine, an aminoacid that is directly involved in lovastatin biosynthetic pathway. Soybean peptone generally allowed the best lovastatin yields to be achieved (250–280 mg l−1), particularly in the presence of soybean and peanut flours. For mevastatin, the best results (300–320 mg l−1) were obtained at 7 days fermentation with modified base medium (CLD), and at 14 days with standard medium (STD), not being possible in this case to associate the best yield with a defined flour and/or peptone. The results show that lovastatin production is influenced by the presence of soybean peptone and by the addition of methionine; instead, the production of mevastatin appears more strictly strain-associated and not directly dependent on the complex ingredients employed.

Key words:

Aspergillus terreus filamentous fungi lovastatin mevastatin statins 


  1. Alberts A.W., Chen J., Kuron G., Hunt V., Huff J., Hoffman C., Rothrock J., Lopez M., Joshua H., Harris E., Patchett A., Monaghan G., Currie S., Stapley E., Albers-Schonberg G., Hensens O., Hirshfield J., Hoogsteen K., Liesch J., Springer J. (1980). Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutarylcoenzyme A reductase and cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA, 77: 3957–3961.CrossRefPubMedGoogle Scholar
  2. Alberts A.W. (1988). Discovery, biochemistry and biology of lovastatin. Am. J. Cardiol., 62: 10J-15J.CrossRefPubMedGoogle Scholar
  3. Chan J.K., Moore R.N., Nakashima T.T., Vederas J.C. (1983). Biosynthesis of mevinolin. Spectral assignment by doublequantum coherence NMR after high carbon-13 incorporation. J. Am. Chem. Soc., 105: 3334–3336.CrossRefGoogle Scholar
  4. Crueger W., Crueger A. (1989). Biotechnology. A Textbook of Industrial Microbiology. Thomas D. Brock, Ed., Sinauer Associates Inc., Sunderland MA, USA.Google Scholar
  5. Endo A., Kuroda M., Tsujita Y. (1976). ML236-A, ML236-B and ML236-C, new inhibitors of cholesterogenesis produced byPenicillium citrinum. J. Antibiot., 29: 1346–1348.PubMedGoogle Scholar
  6. Furberg C.D. (1999). Natural statins and stroke risk. Circulation, 99: 185–188.PubMedGoogle Scholar
  7. Kimura K., Komagata D., Murakawa S., Endo A. (1990). Biosynthesis of monacolins: conversion of monacolin J to monacolin K (mevinolin). J. Antibiot., 43: 1621–1622.PubMedGoogle Scholar
  8. Lai L.-S.T., Pan C.-C., Tzeng B.-K. (2003). The influence of medium design on lovastatin production and pellet formation with a high-producing mutant ofAspergillus terreus submerged cultures. Process Biochem., 38: 1317–1326.CrossRefGoogle Scholar
  9. Manzoni M., Rollini M., Bergomi S., Cavazzoni V. (1998). Production and purification of statins fromAspergillus terreus strains. Biotechnol. Tech., 12: 529–532.CrossRefGoogle Scholar
  10. Manzoni M., Bergomi S., Rollini M., Cavazzoni V. (1999). Production of statins by filamentous fungi. Biotechnol. Lett., 21: 253–257.CrossRefGoogle Scholar
  11. Manzoni M., Rollini M. (2002). Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol., 58: 555–564.CrossRefPubMedGoogle Scholar
  12. Negishi S., Cai-Huang Z., Hasumi K., Murakawa S., Endo A. (1986). Productivity of monacolin K (mevinolin) in the genusMonascus. J. Ferment. Eng., 64: 509–512.Google Scholar
  13. Peng Y., Demain A.L. (1998). A new hydrolase system inActinomadura sp. cells converting compactin to pravastatin. J. Ind. Microbiol. Biotechnol., 20: 373–375.CrossRefGoogle Scholar
  14. Sanchez S., Demain A.L. (2002). Metabolic regulation of fermentation processes. Enzyme Microb. Technol., 31: 895–906.CrossRefGoogle Scholar
  15. Shiao M., Dong H. (1987). Biosynthesis of mevinolin, a hypocholesterolemic fungal metabolite, inAspergillus terreus. Proc. Natl. Sci. Counc., 11: 223–231.Google Scholar
  16. Suryanaryan S., Mazumdar K. (2001). Solid state fermentation. US Patent 6,197,573.Google Scholar
  17. Tobert J.A. (1987). New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl coenzyme A reductase. Circulation, 76: 534–538.PubMedGoogle Scholar

Copyright information

© University of Milan and Springer 2006

Authors and Affiliations

  1. 1.Dipartimento di Scienze e Tecnologie Alimentari e Microbiologiche, Sezione di Microbiologia IndustrialeUniversità degli Studi di MilanoMilanoItaly

Personalised recommendations